Suppr超能文献

生活方式干预在资源有限环境下预防糖尿病的成本效益。

The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting.

机构信息

Department of Endocrinology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, China.

Medical Decision and Economic Group, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, China.

出版信息

J Diabetes Res. 2020 Apr 13;2020:7410797. doi: 10.1155/2020/7410797. eCollection 2020.

Abstract

AIMS

Type 2 diabetes mellitus (T2DM) is a health challenge in China, and the economic outcomes of lifestyle intervention are critically important for policymakers. This study estimates the lifetime economic outcomes of lifestyle intervention among the prediabetic population in the Chinese context.

METHODS

We developed a mathematical model to compare the cost-effectiveness of lifestyle intervention and no prevention in the prediabetic population. Efficacy and safety, medical expenditure, and utility data were derived from the literature, which was assigned to model variables for estimating the quality-adjusted life-years (QALYs) and costs as well as incremental cost-effectiveness ratios (ICERs). The analysis was conducted from the perspective of Chinese healthcare service providers. One-way and probabilistic sensitivity analyses were performed.

RESULTS

Compared with no prevention, lifestyle intervention averted 9.53% of T2DM, which translated into an additional 0.52 QALYs at a saved cost of $700 by substantially reducing the probabilities of macro- and microvascular diseases. This finding indicated that lifestyle intervention was a dominant strategy. The sensitivity analyses showed the model outputs were robust.

CONCLUSIONS

Lifestyle intervention is a very cost-effective alternative for prediabetic subjects and worth implementing in the Chinese healthcare system to reduce the disease burden related to T2DM.

摘要

目的

2 型糖尿病(T2DM)是中国面临的一个健康挑战,生活方式干预的经济结果对于政策制定者至关重要。本研究旨在评估中国糖尿病前期人群生活方式干预的终身经济结果。

方法

我们开发了一个数学模型,以比较糖尿病前期人群中生活方式干预与不预防的成本效益。疗效和安全性、医疗支出以及效用数据来自文献,这些数据被分配给模型变量,以估计质量调整生命年(QALYs)和成本以及增量成本效益比(ICERs)。分析从中国医疗保健服务提供者的角度进行。进行了单因素敏感性分析和概率敏感性分析。

结果

与不预防相比,生活方式干预避免了 9.53%的 T2DM,通过大幅降低大血管和微血管疾病的发生概率,节省了 700 美元的成本,额外获得了 0.52 个 QALYs。这表明生活方式干预是一种主导策略。敏感性分析表明模型结果具有稳健性。

结论

生活方式干预对于糖尿病前期患者来说是一种非常具有成本效益的选择,值得在中国的医疗保健系统中实施,以减轻与 T2DM 相关的疾病负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28a2/7174913/2d428f65ad25/JDR2020-7410797.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验